Nasal Congestion News and Research

RSS

Monkeypox renamed "mpox" in an effort to combat stigma

WHO announces that the monkeypox virus will now be referred to as “mpox” in an effort to reduce the stigmatization of this condition.

29 Nov 2022

Persistent COVID-19 symptoms among South Africans infected during SARS-CoV-2 Beta, Delta and Omicron variant waves

Researchers longitudinally followed up hospitalized (H) and non-hospitalized (NH) COVID-19 patients for six months after laboratory-confirmed SARS-CoV-2 infections to identify factors that increase the risk of post-COVID-19 condition development in the South African population.

4 Nov 2022

FebriDX point-of-care immunoassay can rapidly determine if an infection is bacterial or viral

Researchers explore whether FebriDx could differentiate between bacteria- and virus-induced immune responses during acute respiratory infection.

23 Oct 2022

What is the association of SARS-CoV-2 vaccination with the risk of PASC in patients with SARDs?

Findings of a new study depicted that fully vaccinated patients suffering from systemic autoimmune rheumatic diseases harbor a lower propensity to developing long COVID symptoms compared to SARDs patients who are not fully vaccinated.

11 Oct 2022

The extent of long COVID and its characteristics among the older population

Researchers explored the characteristics of long COVID among older adults.

5 Oct 2022

What is the effect of the Omicron variant on olfaction?

A new study discusses the effect of the Omicron variant of the virus on the olfactory system in humans.

15 Sep 2022

Saline nasal irrigation after COVID-19 diagnosis reduces hospitalization

Starting twice daily flushing of the mucus-lined nasal cavity with a mild saline solution soon after testing positive for COVID-19 can significantly reduce hospitalization and death, investigators report.

13 Sep 2022

Globalization and cessation of smallpox vaccination are influencing monkeypox spread

A recent review by Barbara S. Schnierle of the Paul-Ehrlich-Institut, Germany, and published in the journal Viruses summarized the existing knowledge about MPXV, the disease it causes, and the strategies to curb its spread.

1 Sep 2022

Case report on the post-orgasmic illness treated with antihistamines

Scientists discuss a post-orgasmic illness syndrome patient’s experience of being treated with an antihistamine.

23 Aug 2022

Investigating the missing link between COVID-19 and anosmia

A new study evaluated how SARS-CoV-2 infection leads to anosmia via chromatin structure disruption and OR dysregulation. For this purpose, publicly available Hi-C data of OSNs of SARS-CoV-2-infected and control human subjects were used.

23 Aug 2022

The symptoms and quality of life among individuals with post-acute sequelae of SARS-CoV-2

Researchers evaluated the symptoms and quality of life among individuals with post-acute sequelae of SARS-CoV-2 or PASC.

15 Aug 2022

Doctors discover genetic and viral causes of adenoid hypertrophy in kids

RUDN doctors have discovered genetic and viral causes of a frequent ENT disease in children - adenoid hypertrophy. The results are published in Life.

11 Aug 2022

Fatigue and headache among the most common symptoms following COVID-19 infections

Fatigue and headache were the most common symptoms reported by individuals an average of more than four months out from having COVID-19, investigators report.

8 Aug 2022

COVID-19-induced non-cell-autonomous anosmia

Researchers reported that SARS-CoV-2-induced anosmia was based on non-cell-independent processes.

11 May 2022

Marine bioactive compounds against SARS-CoV-2

A new review paper published in the journal Environmental Science and Pollution Research aimed to determine the possibilities of using biologically active compounds derived from various chemical classes of marine organisms against SARS-CoV-2 infection at various stages of the life cycle of the virus.

6 May 2022

Nasal Congestion News and Research

Monkeypox renamed "mpox" in an effort to combat stigma

Persistent COVID-19 symptoms among South Africans infected during SARS-CoV-2 Beta, Delta and Omicron variant waves

FebriDX point-of-care immunoassay can rapidly determine if an infection is bacterial or viral

What is the association of SARS-CoV-2 vaccination with the risk of PASC in patients with SARDs?

The extent of long COVID and its characteristics among the older population

What is the effect of the Omicron variant on olfaction?

Saline nasal irrigation after COVID-19 diagnosis reduces hospitalization

Globalization and cessation of smallpox vaccination are influencing monkeypox spread

Case report on the post-orgasmic illness treated with antihistamines

Investigating the missing link between COVID-19 and anosmia

The symptoms and quality of life among individuals with post-acute sequelae of SARS-CoV-2

Doctors discover genetic and viral causes of adenoid hypertrophy in kids

Fatigue and headache among the most common symptoms following COVID-19 infections

COVID-19-induced non-cell-autonomous anosmia

Marine bioactive compounds against SARS-CoV-2

Study explores long COVID in adults

Estimating COVID-19 case prevalence in New York City

Omicron outbreak in an indoor convention in New York

NEJM article distills available data into a compendium about rapid diagnostic tests for COVID-19

Study suggests 2/3 of Dutch children < 12 years have been infected with SARS-CoV-2

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News